Withdrawal of Registration Statement (rw)
April 29 2022 - 2:22PM
Edgar (US Regulatory)
InnovaQor,
Inc.
400
South Australian Avenue, Suite 800
West
Palm Beach, Florida 33401
April
29, 2022
VIA
EDGAR
Division
of Corporation Finance
Office
of Technology
Securities
and Exchange Commission
100
F Street, N.E.
Washington,
D.C. 20549
Attn: Olivia Bobes, Matthew Derby, Joseph Kempf and Kathryn Jacobson
Re:
InnovaQor, Inc.
Request
to Withdraw Registration Statement on Form 10, as amended
Filed
March 3, 2022 and April 20, 2022
File
No. 000-33191
Dear
Sirs and Madams:
Pursuant
to Rule 477 promulgated under the Securities Act of 1933, as amended, InnovaQor, Inc., a Nevada corporation (the
“Company”), hereby respectfully requests that the Securities and Exchange Commission consent to the withdrawal of the Registration Statement on Form 10 (SEC File No. 000-33191), filed by the Company on March 3,
2022, as amended by Amendment No. 1 filed by the Company on April 20, 2022 (the “Registration Statement”), in connection
with the registration of the Company’s common stock, par value $0.0001 per share, under Section 12(g) of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”). The Company reserves the right to submit the Registration
Statement at a future date.
In
the absence of this withdrawal application, pursuant to Section 12(g)(1) of the Exchange Act, the Form 10 Registration Statement would
automatically become effective 60 days after the initial filing of the Form 10 Registration Statement. The Company believes that it is
in the best interest of the Company to withdraw the Registration Statement prior to the effective date. Accordingly, the Company respectfully
requests that the Form 10 Registration Statement be withdrawn effective as of the date hereof or at the earliest practical date
but in any event prior to May 1, 2022.
If
you have any questions or require additional information, please do not hesitate to contact the undersigned at (561) 421-3800, or J.
Thomas Cookson of Shutts & Bowen LLP, our outside legal counsel, at (305) 379-9141.
|
Sincerely, |
|
|
|
InnovaQor, Inc. |
|
|
|
By: |
/s/ Sharon L. Hollis |
|
Name: |
Sharon L.
Hollis |
|
Title: |
Chief Executive Officer |
cc: |
J.
Thomas Cookson, Shutts & Bowen LLP |
VisualMED Clinical Solut... (PK) (USOTC:VMCS)
Historical Stock Chart
From Apr 2024 to May 2024
VisualMED Clinical Solut... (PK) (USOTC:VMCS)
Historical Stock Chart
From May 2023 to May 2024